CD38 and acute myeloid leukemia: We compared these DNaseI-seq data from bulk CD34+ AML cells with ATAC-seq data derived from CD34/CD38-sorted LSCs and blasts from t(8;21) #1 and #2 (based on available numbers of cells), and with healthy CD34+ peripheral blood stem cells (PBSCs).